COVID vaccine confidence requires radical transparency.

Nature ; 586(7827): 8, 2020 10.

Article in English | MEDLINE | ID: covidwho-2185682

Subject(s)

Clinical Trials as Topic; Coronavirus Infections/prevention & control; Disclosure; Drug Industry; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Public Opinion; Trust; Viral Vaccines; COVID-19; COVID-19 Vaccines; China; Clinical Trial Protocols as Topic; Clinical Trials as Topic/ethics; Clinical Trials as Topic/standards; Confidentiality/ethics; Confidentiality/legislation & jurisprudence; Coronavirus Infections/epidemiology; Disclosure/ethics; Disclosure/legislation & jurisprudence; Drug Industry/ethics; Drug Industry/legislation & jurisprudence; Drug Industry/standards; Humans; Pneumonia, Viral/epidemiology; Politics; Russia; Safety; United States; Viral Vaccines/adverse effects; Viral Vaccines/pharmacology; Viral Vaccines/standards; Viral Vaccines/therapeutic use

Keywords

Infection; Medical research; Public health; SARS-CoV-2; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Public Opinion / Viral Vaccines / Clinical Trials as Topic / Coronavirus Infections / Disclosure / Trust / Drug Industry / Pandemics Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: North America / Asia / Europa Language: English Journal: Nature Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google